scorecardresearch
Add as a preferred source on Google
Wednesday, November 19, 2025
TopicCoronvirus

Topic: Coronvirus

Celebrities can’t use ‘my body, my choice’ to oppose Covid vaccine. They aren’t special

Morality is not limited to just not causing harm. For better or worse, many people look up to celebrities as people to admire and emulate.

Will China buckle under pressure at Olympics? It has Covid-19, protests against Xi coming

Whatever the outcome, the Chinese govt will revel in its ability to hold a prestigious international event under difficult conditions.

Covid versus vaccine immunity — data on Pfizer shot kicks up great debate again

New data shows CDC erred in telling people that vaccine-induced immunity is better than that acquired from infection. But point of vaccine is to cut risk of infection in the first place.

Bengal govt ready to provide land for manufacturing Covid vaccines — Mamata writes to PM Modi

West Bengal CM Mamata Banerjee called for liberal and proactive import of vaccines and said world players could be encouraged to open up franchise operations in India.

On Camera

India has to move on now. Engage with ‘Nooton Bangladesh’

Former Bangladesh Prime Minister Sheikh Hasina has, in a sense, tasted her own medicine. The International Crimes Tribunal, the special court she instituted for...

The day Dharmendra ‘died’

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

Drone manufacturer ideaForge wins orders worth over Rs 100 crore from Army

ideaForge has formed a joint venture to manufacture and market UAVs in the US. Its Q6 UAV is now included in NATO and allied procurement systems.

INDIA has a Congress-sized hole. And the fix begins with a little humility

Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.